Page last updated: 2024-08-23

swainsonine and Adenocarcinoma, Papillary

swainsonine has been researched along with Adenocarcinoma, Papillary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujieda, S; Hoshino, T; Noda, I; Saito, H; Yagita, M1

Other Studies

1 other study(ies) available for swainsonine and Adenocarcinoma, Papillary

ArticleYear
Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells.
    Archives of otolaryngology--head & neck surgery, 1994, Volume: 120, Issue:4

    Topics: Adenocarcinoma, Papillary; Adjuvants, Immunologic; Cytotoxicity, Immunologic; Fluorescent Antibody Technique; Granzymes; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Serine Endopeptidases; Swainsonine; Thyroid Neoplasms; Tumor Cells, Cultured

1994